US EditionPublished • loading... • Updated
Chinese Company Guizhou Bailin Pharmaceutical co., Ltd. Was Penalized for Inflating Profits by 650 Million Yuan
Summary by 大纪元 Epoch Times
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Guizhou Baili Pharmaceutical Group Co., Ltd. (Guizhou Baili) announced on December 20 that it and its relevant personnel were penalized for inflating profits by 655 million yuan (RMB) over three years. Several other listed companies were also penalized for financial issues. A lawyer stated that Guizhou Baili's maximum penalty indicates the seriousness of its violations.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
